Coccidioidomycosis in patients with hematologic malignancies

Arch Intern Med. 2005 Jan 10;165(1):113-7. doi: 10.1001/archinte.165.1.113.

Abstract

Background: An endemic fungal infection of the desert southwestern United States, coccidioidomycosis is generally a self-limited illness in healthy persons. Immunosuppressed persons who contract coccidioidomycosis, however, are at increased risk for disseminated infection.

Methods: We conducted a retrospective review of patients with coccidioidomycosis and hematologic malignancy or bone marrow disease.

Results: Fifty-five patients were identified. The most common underlying malignancies were non-Hodgkin lymphoma and chronic lymphocytic leukemia. Extrathoracic (or disseminated) infection was observed in 12 patients (22%). Fifteen patients (27%) died with active coccidioidomycosis. Treatment of the hematologic disease with corticosteroids or antineoplastic chemotherapy increased the risk of death.

Conclusion: To date, this is the largest case series of patients with hematologic malignancy and coccidioidomycosis. In persons with hematologic malignancy, coccidioidomycosis can be a severe illness with a high risk for disseminated infection and death.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bone Marrow Diseases / drug therapy
  • Coccidioidomycosis / drug therapy
  • Coccidioidomycosis / etiology*
  • Female
  • Hematologic Neoplasms / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Lymphoma, Non-Hodgkin / drug therapy
  • Male
  • Medical Records
  • Middle Aged
  • Opportunistic Infections / etiology
  • Retrospective Studies
  • Risk Factors
  • Southwestern United States
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents